genprowebdirectory
GEN Edge
News
Insights
Trends for 2020
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Supplement
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Get GEN Edge
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
GEN Edge
Gene Therapy
Laying the Foundation for CF Therapy: An Interview with Michael Boyle
Coronavirus
Beyond the Spike: The COVAXX Approach to a COVID-19 Vaccine
Bioprocessing
Cytiva Plans $500M Expansion, 1,000 New Hires Worldwide
Coronavirus
A ‘Human’ Touch vs. COVID-19
Gene Therapy
AGTC Sets Sights on Late-Stage Retinitis Pigmentosa Gene Therapy Trial
News
Alzheimers
Fructose Metabolism in Brain May Help Initiate Alzheimer’s Disease
Coronavirus
J&J’s Janssen Launches Up-to-60,000-Patient Phase III Trial for COVID-19 Vaccine
Coronavirus
Closer Look at SARS-CoV-2 Protein Glycans Points to New Therapeutic and…
3D Printing
3D Printed Kidneys Included in CollPlant and United Therapeutics’ Expanded Collaboration
Imaging analysis
Cellular Force Visible at Molecular Scale Using PAINT Imaging
Insights
All
Trends for 2020
A-Lists
Top 50 NIH-Funded Institutions of 2020
Bioprocessing
Genetic Engineering Across the Tree of Life
Coronavirus
Controversy Aside, Why the Source of COVID-19 Matters
Bioprocessing
Sensors Take on Undersampling in Biomanfacturing
A-Lists
A-Lists
Top 50 NIH-Funded Institutions of 2020
July 2020 Vol. 40 No. 7
Top 10 Earners among Women Biopharma Executives
June 2020 Vol. 40 No. 6
In Praise of Lesser-Sung Life Sciences Clusters
Coronavirus
Blinking Red: 25 Missed Pandemic Warning Signs
Coronavirus
Vanquishing the Virus: 160+ COVID-19 Drug and Vaccine Candidates in Development
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Upcoming Webinars
The Life and Times of Rosalind Franklin
Coronavirus
J&J’s Janssen Launches Up-to-60,000-Patient Phase III Trial for COVID-19 Vaccine
3D Printing
3D Printed Kidneys Included in CollPlant and United Therapeutics’ Expanded Collaboration
Antibodies
Lupus Patients Treated Successfully with mAb Targeting Plasma Cells
Magazine
All
Supplement
September 2020 Vol. 40 No. 9
Cold Cases Heat Up with New Forensic DNA Methods
September 2020 Vol. 40 No. 9
CRISPR Value Chains Support New Therapeutic Strategies
September 2020 Vol. 40 No. 9
Nonviral CRISPR Delivery Vehicles Lay the Smart Siege
Point of View
Multimodal Screening—The Future of Drug Discovery and Development
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Home
Companies
Amgen
Amgen
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Amgen
Amgen Expands China Presence, Cancer R&D with $2.7B BeiGene Collaboration
Amgen
Amgen Eyes Inflammatory Disease Expansion with Planned $13.4B Purchase of Celgene’s Otezla
Amgen
Amgen Offers $167M for Cancer Collaboration Partner Nuevolution
Amgen
Amgen, Entera to Partner on Oral Drugs for Inflammatory Disease, Other “Serious” Illnesses
Amgen
Amgen Selects Second Cancer Target in 2-Year-Old Collaboration with Nuevolution
Amgen
Amgen, MD Anderson Launch Two Cancer Collaborations
Amgen
Amgen, Novartis Set to Launch Migraine Drug Aimovig Next Week after...
Amgen
Federal Circuit Favors Novartis’ Sandoz over Amgen in Biosimilar “Patent Dance”...
Amgen
Amgen, Novartis Expand Alzheimer’s Collaboration with New Trial
Amgen
Amgen, CytomX Launch Up-to-$1.465B+ Cancer Immunotherapy Collaboration
Amgen
Amgen Delaying U.S. Launch of Humira Biosimilar in Settlement with AbbVie
Amgen
After FDA Approval, Amgen–Allergan Cancer Biosimilar Mvasi Faces Launch, Pricing Challenges
Amgen
FDA to Review BLA for Amgen-Novartis Migraine Prevention Treatment
Amgen
Amgen Licenses Ligand’s Captisol Technology for AML Candidate AMG 330
Amgen
FDA Rejects Amgen-UCB Osteoporosis Candidate Evenity
Load more
Scroll Up
Please share your location to continue
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
/* The alert message box */ .alert { padding: 20px; background-color: #ff9800; /* Red */ color: white; margin-bottom: 15px; } /* The close button */ .closebtn { margin-left: 15px; color: white; font-weight: bold; float: right; font-size: 22px; line-height: 20px; cursor: pointer; transition: 0.3s; } /* When moving the mouse over the close button */ .closebtn:hover { color: black; } .td_module_flex_2 .entry-title { font-size: 17px; line-height: 20px; }
